Search Results - "SATTERWHITE, J"

Refine Results
  1. 1

    Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease by SIEMERS, E. R, QUINN, J. F, SATTERWHITE, J, GONZALES, C, DEAN, R. A, MAY, P. C, KAYE, J, FARLOW, M. R, PORSTEINSSON, A, TARIOT, P, ZOULNOUNI, P, GALVIN, J. E, HOLTZMAN, D. M, KNOPMAN, D. S

    Published in Neurology (28-02-2006)
    “…LY450139 dihydrate, a gamma-secretase inhibitor, was studied in a randomized, controlled trial of 70 patients with Alzheimer disease. Subjects were given 30 mg…”
    Get full text
    Journal Article
  2. 2

    MondoA-Mlx Heterodimers Are Candidate Sensors of Cellular Energy Status: Mitochondrial Localization and Direct Regulation of Glycolysis by Sans, Christopher L., Satterwhite, Daniel J., Stoltzman, Carrie A., Breen, Kevin T., Ayer, Donald E.

    Published in Molecular and Cellular Biology (01-07-2006)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis by Chen, Peiqi, Satterwhite, Julie H, Licata, Angelo A, Lewiecki, E Michael, Sipos, Adrien A, Misurski, Derek M, Wagman, Rachel B

    Published in Journal of bone and mineral research (01-06-2005)
    “…The relationship between early changes in biochemical markers of bone turnover and the subsequent BMD response to daily teriparatide therapy in women with…”
    Get full text
    Journal Article
  4. 4

    A thermodynamic analysis of end-directed particle flocking in chemical systems by De Bari, B., Dixon, J., Pateras, J., Rusling, J., Satterwhite-Warden, J., Vaidya, A.

    “…We discuss the thermodynamics behind self-organizing Benzoquinone (BQ) particles on air–water interface. Experiments (Satterwhite-Warden et al., 2015; Chen…”
    Get full text
    Journal Article
  5. 5

    Feasibility and Acceptability of a Pharmacogenomic Decision Support System in Palliative Care by Bull, Janet H, Bice, Tyler, Satterwhite, Wesley J, Massie, Lisa, Burpee, Elizabeth, Knotkova, Helena, Portenoy, Russell K

    Published in Journal of palliative medicine (01-02-2022)
    “…Pharmacogenomic analysis may improve the efficacy or safety of the drugs used in palliative care. Decision support systems may promote clinical integration of…”
    Get more information
    Journal Article
  6. 6

    Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure by Frolik, Charles A, Black, Elwood C, Cain, Ricky L, Satterwhite, Julie H, Brown-Augsburger, Patricia L, Sato, Masahiko, Hock, Janet M

    Published in Bone (New York, N.Y.) (01-09-2003)
    “…Parathyroid hormone (PTH)(1-34), given once daily, increases bone mass in a variety of animal models and humans with osteoporosis. However, continuous PTH…”
    Get full text
    Journal Article
  7. 7

    The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-β Signaling by Blocking Binding of the Smad Complex to Its Target Sequence by Lee, Dug Keun, Kim, Byung-Chul, Kim, Isaac Yi, Cho, Eun-ah, Satterwhite, Daniel J., Kim, Seong-Jin

    Published in The Journal of biological chemistry (11-10-2002)
    “…The human papillomavirus (HPV) oncoprotein E7 is implicated in the etiology of cervical cancer associated with infection by HPV. HPV-positive cells develop…”
    Get full text
    Journal Article
  8. 8

    TGF‐β induces novel Lef‐1 splice variants through a Smad‐independent signaling pathway by Cordray, Pauline, Satterwhite, Daniel J.

    Published in Developmental dynamics (01-04-2005)
    “…The lymphoid enhancer‐binding factor (Lef‐1) transcription factor is best known for the ability to transduce Wnt signals during development and to mediate…”
    Get full text
    Journal Article
  9. 9

    TGF-beta targets the Wnt pathway components, APC and beta-catenin, as Mv1Lu cells undergo cell cycle arrest by Satterwhite, Daniel J, Neufeld, Kristi L

    Published in Cell cycle (Georgetown, Tex.) (01-08-2004)
    “…The highly coordinated interaction of TGF-beta and Wnt signaling pathways is critical for normal development. However, the effects of TGF-beta on APC and…”
    Get full text
    Journal Article
  10. 10

    Use of IV isoproterenol test as a biomarker in a first-in-man study: Pilot investigation with LY, a combined beta3 agonist/beta1 antagonist by Satterwhite, J., Virgilio, S., VanLier, J.J., Gaich, G., Chalon, S.

    Published in Clinical pharmacology and therapeutics (01-02-2005)
    “…Background LY is a selective β3‐agonist with β1‐antagonist properties that is expected to induce a β3‐mediated increase in thermogenesis. The IV isoproterenol…”
    Get full text
    Journal Article
  11. 11

    The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease by Bodick, N C, Offen, W W, Shannon, H E, Satterwhite, J, Lucas, R, van Lier, R, Paul, S M

    “…The therapeutic effects of selective cholinergic replacement using oral xanomeline, an m1/m4 receptor agonist, were assessed in a multicenter study of 343…”
    Get more information
    Journal Article
  12. 12

    The safety and tolerance of xanomeline tartrate in patients with Alzheimer's disease by Sramek, J J, Hurley, D J, Wardle, T S, Satterwhite, J H, Hourani, J, Dies, F, Cutler, N R

    Published in Journal of clinical pharmacology (01-08-1995)
    “…Xanomeline tartrate (active ingredient xanomeline) is a muscarinic agonist that has demonstrated specificity for the M1 receptor in preclinical studies and has…”
    Get more information
    Journal Article
  13. 13

    TGF-β Targets the Wnt Pathway Components, APC and β-catenin, as Mv1Lu Cells Undergo Cell Cycle Arrest by Satterwhite, Daniel J., Neufeld, Kristi L.

    Published in Cell cycle (Georgetown, Tex.) (21-08-2004)
    “…The highly coordinated interaction of TGF-? and Wnt signaling pathways is critical for normal development. However, the effects of TGF-β on APC and…”
    Get full text
    Journal Article
  14. 14

    The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis by Marcus, Robert, Wang, Ouhong, Satterwhite, Julie, Mitlak, Bruce

    Published in Journal of bone and mineral research (01-01-2003)
    “…In a recent study of women with postmenopausal osteoporosis, treatment with teriparatide for a median of 19 months increased bone mineral density and decreased…”
    Get full text
    Journal Article
  15. 15

    Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers by Siemers, Eric, Skinner, Michael, Dean, Robert A, Gonzales, Celedon, Satterwhite, Julie, Farlow, Martin, Ness, Daniel, May, Patrick C

    Published in Clinical neuropharmacology (01-05-2005)
    “…Amyloid beta (Abeta) may play a central role in the pathogenesis of Alzheimer disease. A functional gamma-secretase inhibitor, LY450139, was developed that…”
    Get full text
    Journal Article
  16. 16

    Effects of age and dose on the pharmacokinetics of ibuprofen in the rat by Satterwhite, J H, Boudinot, F D

    Published in Drug metabolism and disposition (01-01-1991)
    “…The pharmacokinetics of ibuprofen after 2.5 and 25 mg/kg doses were examined in young adult (5 months) and senescent (24 months) male Fischer 344 rats. Plasma…”
    Get more information
    Journal Article
  17. 17

    Social Compatibility as a Consideration in Caring for Nursing Home Residents With Dementia by Cherry, Barbara, Carpenter, Ken, Waters, Cheryl, Hawkins, W.W., McGrew, Pamela, Satterwhite, Leah J., Stepien, Julie, Ruppelt, Wanda, Herring, Kent

    “…A major challenge for caregivers in nursing homes is to provide high-quality, person-centered care to a large population of residents with Alzheimer's disease…”
    Get full text
    Journal Article
  18. 18

    Effects of age on the pharmacodynamics of naproxen in the rat by Satterwhite, Julia H., Boudinot, F.Douglas

    Published in Experimental gerontology (01-09-1995)
    “…The pharmacodynamics of naproxen were evaluated in 5- and 24-month-old male Fischer 344 rats. Plasma naproxen concentrations and thromboxane B2 (T×B 2)…”
    Get full text
    Journal Article
  19. 19

    Pharmacokinetics of ketoprofen in rats: effect of age and dose by Satterwhite, J H, Boudinot, F D

    Published in Biopharmaceutics & drug disposition (01-04-1992)
    “…The effects of age and dose on the pharmacokinetics of ketoprofen were evaluated in young adult and senescent male Fischer 344 rats following intravenous…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics of cefaclor AF: effects of age, antacids and H2-receptor antagonists by Satterwhite, J H, Cerimele, B J, Coleman, D L, Hatcher, B L, Kisicki, J, DeSante, K A

    Published in Postgraduate medical journal (1992)
    “…The pharmacokinetics and bioavailability of cefaclor advanced formulation (cefaclor AF) were investigated in two studies, one comparing healthy elderly and…”
    Get full text
    Journal Article